What it's for (Indications)
- Carbomer and medium chain triglycerides ophthalmic preparations are primarily indicated for the symptomatic treatment and relief of various forms of dry eye syndrome.
- This includes alleviation of symptoms such as burning, stinging, irritation, foreign body sensation, and discomfort associated with inadequate tear production or excessive tear evaporation.
- These formulations are particularly beneficial for individuals experiencing moderate to severe dry eye, chronic ocular surface dryness, or those requiring prolonged lubrication, especially during nocturnal hours or extended periods of visual strain.
- Their unique composition helps to stabilize the natural tear film, providing sustained moisture and protection to the ocular surface, thereby promoting comfort and reducing ocular surface damage caused by dryness.
- This therapeutic approach aims to restore ocular surface homeostasis and improve overall patient quality of life.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical dosage for ophthalmic preparations containing carbomer and medium chain triglycerides is one drop applied to the conjunctival sac of the affected eye(s) as needed, generally before sleep for sustained overnight relief, or as frequently as prescribed by a qualified ophthalmologist or healthcare professional based on the severity of the dry eye condition. Due to the viscous nature of the gel, which provides prolonged contact time with the ocular surface, application frequency is often less than that of standard aqueous eye drops. Patients should be advised to follow specific product instructions regarding administration frequency, and to ensure proper hand hygiene before application to prevent microbial contamination. The precise dosing regimen should always be determined by a healthcare provider after a thorough assessment of the patient's individual clinical needs and response to therapy. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated, ophthalmic preparations containing carbomer and medium chain triglycerides may cause a few transient side effects.
- The most common immediate side effect is temporary blurred vision or a hazy sensation, which typically resolves within a few minutes after application due to the gel's viscosity.
- Other mild ocular irritations can include a temporary stinging or burning sensation, slight redness, or a foreign body sensation.
- Rarely, individuals may experience signs of hypersensitivity reactions, such as allergic conjunctivitis, itching, increased redness, swelling of the eyelids, or rash, indicative of an allergic response to any component of the formulation.
- Should any severe or persistent adverse reactions occur, or if symptoms worsen or do not improve with use, immediate discontinuation and consultation with a healthcare professional are strongly recommended to assess the cause and appropriate management plan.
Serious Warnings
- Black Box Warning: **NO BLACK BOX WARNING.** Ophthalmic preparations containing carbomer and medium chain triglycerides, such as Artelac Nighttime, are generally considered safe and well-tolerated for the management of dry eye syndrome. There is no formal FDA-issued Black Box Warning associated with this specific class of ophthalmic lubricants, indicating that they do not carry severe, life-threatening risks that warrant such a prominent warning. However, despite the absence of a black box warning, it is imperative to adhere to the following serious safety warnings: Patients should immediately discontinue use and seek urgent medical attention if they experience severe ocular pain, persistent vision changes, signs of a serious allergic reaction (e.g., severe swelling, difficulty breathing), or if ocular symptoms of dryness, redness, or irritation significantly worsen or fail to improve within a few days of consistent and appropriate use. Contamination risk is also serious; avoid touching the applicator tip to prevent potential severe ocular infection that could lead to vision impairment.
- For ophthalmic use only.
- Patients should be advised to discontinue use and consult a healthcare professional immediately if they experience persistent eye pain, changes in vision, continued redness or irritation of the eye, or if their dry eye symptoms persist or worsen after 72 hours of consistent use.
- Individuals who wear contact lenses must remove them prior to application of this viscous gel and wait for at least 15 minutes before reinserting them, as the gel can adhere to contact lenses, causing discomfort or lens spoilage.
- To prevent contamination of the product and potential severe eye infection, users must avoid touching the tip of the container to the eye, eyelids, or any other surface.
- This product may cause temporary blurred vision; therefore, caution should be exercised when driving or operating machinery immediately after application until vision clears completely and vision is stable.
How it Works (Mechanism of Action)
This ophthalmic formulation combines two distinct but synergistic mechanisms to alleviate dry eye symptoms by stabilizing and supplementing the natural tear film. Carbomer, a high molecular weight polyacrylic acid polymer, acts as a hydrophilic demulcent and ocular lubricant. Upon contact with the ocular surface, it forms a viscous, protective, and hydrating film that mimics the aqueous layer of the natural tear film. This increases the viscosity of the tear film, prolonging its retention time and enhancing lubrication, thereby reducing friction and promoting epithelial healing. Medium chain triglycerides (MCTs), as lipophilic components, integrate into and stabilize the lipid layer of the tear film. This stabilization reduces excessive evaporation of the aqueous layer, a common underlying cause of evaporative dry eye. Together, these components effectively address both aqueous deficiency and evaporative components of dry eye syndrome, providing comprehensive and sustained ocular surface hydration and protection.
Commercial Brands (Alternatives)
No other brands found for this formula.